Here are five key points:
1. Xtant reported Mr. Goldberger resigned as CEO and a director of the company and its subsidiaries to pursue other interests.
2. Xtant’s President Carl O’Connell will take on the interim CEO position as the company’s board decides on a permanent CEO.
3. Mr. O’Connell has been with the company since October 2016.
4. Prior to joining Xtant, Mr. O’Connell held leadership roles at Memphis, Tenn.-based Wright Medical Group and Fairfield, Conn.-based Calmare Therapeutics, among others.
5. Kent Swanson, board of directors’ chairman, commented, “Under Dan’s leadership, the company has made significant progress toward our strategic goal.”
More articles on devices:
Why 2017 is a big year for minimally invasive spine surgery: Q&A with Paradigm Spine Chairman & CEO Marc Viscogliosi
Global orthopedic devices market to grow at 5% CAGR through 2022 — 3 observations
Zimmer Biomet, Implanet, Spinal Elements & more: 8 device company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
